Answers are grounded in this paper and cite their sources.
Shows remifentanil boluses reduce systolic blood pressure and heart rate without altering histamine levels, suggesting hemodynamic changes occur independently of histamine release.
Remifentanil is a new potent opioid analgesic that undergoes rapid esterase metabolism.The purpose of this study was to investigate hemodynamic responses to 2-30 micro gram/kg remifentanil (escalating doses) injected as a bolus over 1 min during general anesthesia. After general anesthesia with endotracheal intubation, placement of a radial artery catheter, and pretreatment with glycopyrrolate, remifentanil 2, 5, 15, or 30 micro gram/kg (six patients, three male and three female per group) was administered over 1 min. Arterial blood pressure and heart rate were measured noninvasively before drug administration, after drug administration, and then every minute for 5 min. Arterial blood was taken for histamine determinations before drug administration and then at 1, 3, and 5 min after drug administration. Administration of remifentanil was associated with a reduction in systolic blood pressure from 134 +/- 18 to 91 +/- 16 mm Hg and heart rate from 99 +/- 20 to 69 +/- 21 bpm and was not associated with alterations in histamine concentration. (Anesth Analg 1995;80:990-3)
No takes yet. Share an insight, caveat, or question.
Sebel et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: